DYNE THERAPEUTICS INC

Dyne Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights

04 3 2021 06:35:00 提供 Nasdaq GlobeNewswire

Dyne Therapeutics Appoints Wildon Farwell, M.D., MPH, as Chief Medical Officer

04 3 2021 06:25:00 提供 Nasdaq GlobeNewswire

Dyne Therapeutics Appoints Ashish Dugar, Ph.D., MBA, Senior Vice President, Global Head of Medical Affairs

08 2 2021 06:30:00 提供 Nasdaq GlobeNewswire

Dyne Therapeutics Announces Pricing of $168 Million Public Offering

20 1 2021 19:05:29 提供 Nasdaq GlobeNewswire

Dyne Therapeutics Myotonic Dystrophy Type 1 Program Achieves Robust RNA Knock Down of Toxic Human Nuclear DMPK in Preclinical Study

10 1 2021 14:00:00 提供 Nasdaq GlobeNewswire

Dyne Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference

05 1 2021 06:30:00 提供 Nasdaq GlobeNewswire